Education
About Us
Working with TipRanks
Follow Us
PILA PHARMA AB (DE:5KC)
FRANKFURT:5KC
5KC Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.15 - €0.49
Previous CloseN/A
Volume2.28K
Average Volume (3M)83.00
Market Cap
€8.18M
Enterprise Value€77.99M
Total Cash (Recent Filing)€2.54M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
Beta0.28
Next Earnings
Feb 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding42,084,415
10 Day Avg. Volume250
30 Day Avg. Volume83
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
5KC FAQ
What was PILA PHARMA AB’s price range in the past 12 months?
PILA PHARMA AB lowest stock price was €0.15 and its highest was €0.49 in the past 12 months.
What is PILA PHARMA AB’s market cap?
PILA PHARMA AB’s market cap is €8.18M.
When is PILA PHARMA AB’s upcoming earnings report date?
PILA PHARMA AB’s upcoming earnings report date is Feb 26, 2026 which is in 149 days.
How were PILA PHARMA AB’s earnings last quarter?
PILA PHARMA AB released its earnings results on Aug 27, 2025. The company reported -€0.012 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.012.
Is PILA PHARMA AB overvalued?
According to Wall Street analysts PILA PHARMA AB’s price is currently Overvalued.
Does PILA PHARMA AB pay dividends?
PILA PHARMA AB does not currently pay dividends.
What is PILA PHARMA AB’s EPS estimate?
PILA PHARMA AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PILA PHARMA AB have?
PILA PHARMA AB has 42,084,415 shares outstanding.
What happened to PILA PHARMA AB’s price movement after its last earnings report?
PILA PHARMA AB reported an EPS of -€0.012 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.556%.
Which hedge fund is a major shareholder of PILA PHARMA AB?
Currently, no hedge funds are holding shares in DE:5KC
Company Description
PILA PHARMA AB
PILA PHARMA AB (publ) operates as a clinical stage pharmaceutical company in Sweden. It is developing XEN-D0501, a TRPV1 antagonist that has completed two phase 2a clinical trials for type 2 diabetes. PILA PHARMA AB (publ) was incorporated in 2014 and is based in Malmö, Sweden.
Technical Analysis
Biosergen AB
―
Lipigon Pharmaceuticals AB
―
ExpreS2ion Biotech Holding AB
―
NextCell Pharma AB
―
Spago Nanomedical AB
―